Bio Green Med Solution, Inc. (BGMS) shareholders
Close on Nov 17, 2026Market cap $3.91MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Steven Boyd Joint filing with Armistice Capital, LLC (9.20%) | 24,844,725 | 9.20% | 13G (passive) amendment | Mar 31, 2025 |
| Doris Wong Sing Ee | 1,111,131 | 20.58% | 13D (active) amendment | Nov 12, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of BGMS | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Citadel Advisors LLC | 75,240 | – | $68.47K | +53,189 | 0.00% |
| Jane Street Group, LLC | 16,291 | – | $14.83K | New | 0.00% |
| Tower Research Capital LLC (TRC) | 5,722 | – | $5.21K | +1,461 | 0.00% |
| UBS Group AG | 4,332 | – | $3.94K | +2,163 | 0.00% |
| SBI Securities Co., Ltd. | 701 | – | $638 | +201 | 0.00% |
| Archer Investment Corp | 2 | – | $2 | +1 | 0.00% |
| Osaic Holdings, Inc. | 1 | – | $0 | – | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|
| Q2 2026 | 7 | 0M | 1 / 5 | 0 / 3 | 0M | 0M |
| Q1 2026 | 9 | 0M | 3 / 4 | 0 / 3 | 0M | 0M |
| Q4 2025 | 9 | 0M | 3 / 2 | 1 / 0 | 0M | 0M |
| Q3 2025 | 6 | 0M | 5 / 0 | 1 / 0 | 0M | 0M |
| Q2 2025 | 1 | 0M | 1 / 0 | 0 / 0 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
1 funds held BGMS in Q2 2026, 0% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of BGMS | Value | % of fund | As of |
|---|---|---|---|---|---|
| Fidelity Extended Market Index Fund | 16,327 | – | $17.96K | 0.00% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | Latest filing |
|---|---|---|---|
| Wong Sing Ee Doris | Chief Executive Officer, Director, 10% owner | 1,111,131 | Nov 13, 2025 |
| Cu Seng Kiu | Chief Financial Officer, Director | 200,000 | Nov 13, 2025 |
| Krishnan Satis Waran Nair | Director | 0 | May 2, 2025 |
| Inigo Angel Laurduraj | Director | 0 | May 2, 2025 |
| Avraham Ben-Tzvi | Director | 0 | Feb 28, 2025 |
| David Natan | Director | 0 | Feb 28, 2025 |
| Kwang Fock Chong | Director | 0 | Feb 28, 2025 |
| Yee Lung Ong | 10% owner | 467,535 | Nov 5, 2025 |
| Kim Choy Yap | 10% owner | 0 | Nov 5, 2025 |
| Khai Loon Kua | 10% owner | 467,535 | Nov 5, 2025 |
| Diversified Berhad FITTERS | 10% owner | 279,248 | Oct 23, 2025 |
| David E. Lazar | 10% owner | 155,838 | Aug 4, 2025 |
| Sukses Engineering Sdn Bhd Suria | – | 250,000 | May 30, 2025 |
| Kee Wee Ho | – | 250,000 | May 30, 2025 |
| Kok Hui Tan | – | 250,000 | May 30, 2025 |
| Jien Shiung Ho | – | 250,000 | May 30, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Cu Seng Kiu Chief Financial Officer, Director | Nov 12, 2025 | Award | +200,000 | $1.40 | $280.00K | 200,000 |
| Wong Sing Ee Doris Chief Executive Officer, Director, 10% owner | Nov 12, 2025 | Award | +300,178 | $1.40 | $420.25K | 1,111,131 |
| Khai Loon Kua 10% owner | Nov 5, 2025 | Other | +467,535 | – | – | 467,535 |
| Yee Lung Ong 10% owner | Nov 5, 2025 | Other | +467,535 | – | – | 467,535 |
| Kim Choy Yap 10% owner | Nov 5, 2025 | Sale | −28,540 | $1.70 | $48.52K | 0 |
| Kim Choy Yap 10% owner | Nov 5, 2025 | Other | +467,535 | – | – | 467,535 |
| Kim Choy Yap 10% owner | Oct 30, 2025 | Sale | −112,260 | $1.81 | $203.19K | 28,500 |
| Khai Loon Kua 10% owner | Oct 30, 2025 | Sale | −242,477 | $1.80 | $436.46K | 0 |
| Yee Lung Ong 10% owner | Oct 30, 2025 | Sale | −248,814 | $1.80 | $447.87K | 0 |
| Kim Choy Yap 10% owner | Oct 29, 2025 | Sale | −110,749 | $1.83 | $202.67K | 140,760 |
| Kim Choy Yap 10% owner | Oct 28, 2025 | Sale | −13,111 | $1.83 | $23.99K | 251,509 |
| Kim Choy Yap 10% owner | Oct 27, 2025 | Sale | −120,250 | $2.12 | $254.93K | 264,620 |
| Kim Choy Yap 10% owner | Oct 24, 2025 | Sale | −19,595 | $1.90 | $37.23K | 384,870 |
| Yee Lung Ong 10% owner | Oct 24, 2025 | Sale | −19,858 | $1.99 | $39.52K | 248,814 |
| Diversified Berhad FITTERS 10% owner | Oct 21, 2025 | Sale | −92,352 | $3.01 | $277.98K | 279,248 |
| Diversified Berhad FITTERS 10% owner | Oct 20, 2025 | Sale | −108,107 | $3.09 | $334.05K | 371,600 |
| Khai Loon Kua 10% owner | Oct 16, 2025 | Sale | −88,204 | $4.22 | $372.22K | 242,477 |
| Diversified Berhad FITTERS 10% owner | Oct 16, 2025 | Sale | −26,051 | $5.50 | $143.28K | 479,707 |
| Khai Loon Kua 10% owner | Oct 15, 2025 | Sale | −7,479 | $5.66 | $42.33K | 330,681 |
| Yee Lung Ong 10% owner | Oct 14, 2025 | Sale | −135,793 | $6.00 | $814.76K | 268,672 |
| Diversified Berhad FITTERS 10% owner | Oct 10, 2025 | Sale | −51,400 | $5.26 | $270.36K | 505,758 |
| Diversified Berhad FITTERS 10% owner | Oct 8, 2025 | Sale | −142,000 | $5.29 | $751.18K | 557,158 |
| Khai Loon Kua 10% owner | Sep 16, 2025 | Sale | −25,000 | $5.13 | $128.25K | 338,160 |
| Khai Loon Kua 10% owner | Sep 12, 2025 | Sale | −22,251 | $6.22 | $138.40K | 363,160 |
| Khai Loon Kua 10% owner | Sep 5, 2025 | Sale | −19,054 | $7.01 | $133.57K | 385,411 |
| Kim Choy Yap 10% owner | Sep 4, 2025 | Other | +186,465 | – | – | 404,465 |
| Yee Lung Ong 10% owner | Sep 4, 2025 | Other | +186,465 | – | – | 404,465 |
| Khai Loon Kua 10% owner | Sep 4, 2025 | Other | +186,465 | – | – | 404,465 |
| David E. Lazar 10% owner | Jul 30, 2025 | Sale | −6,750 | $12.36 | $83.43K | 155,838 |
| David E. Lazar Interim CEO, 10% owner | Feb 26, 2025 | Option exercise | +191,978,820 | – | – | 194,628,820 |
| David E. Lazar Interim CEO, 10% owner | Feb 26, 2025 | Option exercise | +2,650,000 | – | – | 2,650,000 |
| David E. Lazar Interim CEO, 10% owner | Feb 26, 2025 | Sale | −194,628,820 | $0.03 | $5.84M | 0 |
| David Natan Director | Jan 2, 2025 | Award | +100,000 | – | – | 100,000 |
| Brian Schwartz Interim Chief Medical Officer, Director | Jan 29, 2024 | Award | +12,500 | – | – | 15,205 |
| Spiro George Rombotis President and CEO, Director | Dec 21, 2023 | Buy | +6,070 | $3.32 | $20.15K | 68,658 |
| Paul McBarron See Remarks, Director | Dec 21, 2023 | Buy | +1,886 | $3.32 | $6.26K | 33,378 |
| Robert J. Spiegel Director | Jun 30, 2023 | Award | +21,219 | – | – | 39,415 |
| Brian Schwartz Director | Jun 30, 2023 | Award | +21,219 | – | – | 40,602 |
| Kenneth M. Ferguson Director | Jun 30, 2023 | Award | +21,219 | – | – | 44,952 |
| Sam L. Barker Director | Jun 30, 2023 | Award | +21,219 | – | – | 40,415 |
| Christopher S. Henney Director | Jun 30, 2023 | Award | +21,219 | – | – | 39,415 |
| Karin L. Walker Director | Jun 30, 2023 | Award | +21,219 | – | – | 40,602 |
| Mark Kirschbaum Chief Medical Officer | Jan 31, 2023 | Award | +31,200 | – | – | 31,200 |
| Spiro George Rombotis President and CEO, Director | Jan 31, 2023 | Award | +57,600 | – | – | 62,588 |
| Paul McBarron See Remarks, Director | Jan 31, 2023 | Award | +31,200 | – | – | 31,492 |
| Kenneth M. Ferguson Director | Jun 14, 2022 | Award | +23,733 | – | – | 23,733 |
| Lloyd Sems Director | Jun 14, 2022 | Award | +15,822 | – | – | 18,196 |
| Christopher S. Henney Director | Jun 14, 2022 | Award | +15,822 | – | – | 18,196 |
| Karin L. Walker Director | Jun 14, 2022 | Award | +15,822 | – | – | 19,383 |
| Robert J. Spiegel Director | Jun 14, 2022 | Award | +15,822 | – | – | 18,196 |
| Brian Schwartz Director | Jun 14, 2022 | Award | +15,822 | – | – | 19,383 |
| Sam L. Barker Director | Jun 14, 2022 | Award | +15,822 | – | – | 19,196 |
| Kenneth M. Ferguson Director | Jun 14, 2022 | Award | +27,733 | – | – | 27,733 |
| Sam L. Barker Director | Nov 30, 2021 | Sale | −12 | $3.57 | $43 | 3,374 |
| Spiro George Rombotis President and CEO, Director | Nov 18, 2021 | Buy | +4,000 | $4.50 | $18.00K | 4,988 |
| Sam L. Barker Director | Aug 24, 2021 | Buy | +1,000 | $5.00 | $5.00K | 3,386 |
| Gregory T. Hradsky Director | Jun 15, 2021 | Award | +2,374 | – | – | 2,374 |
| Sam L. Barker Director | Jun 15, 2021 | Award | +2,374 | – | – | 2,386 |
| Christopher S. Henney Director | Jun 15, 2021 | Award | +2,374 | – | – | 2,374 |
| Karin L. Walker Director | Jun 15, 2021 | Award | +1,187 | – | – | 3,561 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Bio Green Med Solution's stock actually held short. Settlement fails (shares not delivered on time) peaked at 13,260 shares on Sep 15, 2026 over the last 90 days.
See a number that looks wrong?